Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Daicel Corporation    4202   JP3485800001

DAICEL CORPORATION

(4202)
  Report
End-of-day quote. End-of-day quote Tokyo Stock Exchange - 01/19
762 JPY   -0.26%
2020DAICEL CORPORATION : Ex-dividend day for interim dividend
FA
2020DAICEL CORPORATION : Ex-dividend day for final dividend
FA
2020DAICEL CORPORATION : Anniversary bonus dividend
FA
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animals

03/23/2020 | 08:48pm EST

Japanese biopharmaceutical firm Anges Inc said on Tuesday that it and Osaka University had completed development of a DNA vaccine against the new coronavirus and that it would begin testing it in animals soon.

Shares of Anges surged as much as 17% in morning trade in Tokyo, compared with a 5.3% gain in the broader market.

Anges, a drug-discovery company launched out of Osaka University, announced its collaboration with the school on a coronavirus vaccine on March 5. DNA vaccines are produced using an inactivated virus and can manufactured faster than protein based vaccines, according to the company statement.

Takara Bio Co is in charge of production of the vaccine and Daicel Corp's gene-transfer technology is also being utilized, the statement said.

Global pharma companies are racing to develop vaccines and treatments for coronavirus, which has reached 350,000 cases globally and resulted in over 15,000 deaths.

In Japan, market leader Takeda Pharmaceutical Co is working on a plasma-derived therapy, while the active ingredient in Fujifilm Holdings Corp's Avigan anti-flu drug is being tested as a treatment in China.

(Reporting by Chang-Ran Kim and Rocky Swift; Editing by Kim Coghill)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ANGES, INC. 0.16% 1260 End-of-day quote.1.20%
DAICEL CORPORATION -0.26% 762 End-of-day quote.1.20%
DISCOVERY, INC. -1.66% 36.15 Delayed Quote.20.14%
FUJIFILM HOLDINGS CORPORATION 1.26% 6171 End-of-day quote.13.48%
LETS HOLDINGS GROUP CO., LTD. -2.33% 7.53 End-of-day quote.-3.21%
LINE CORPORATION 0.00% 5350 End-of-day quote.0.00%
LOOK HOLDINGS INCORPORATED -0.76% 914 End-of-day quote.-4.49%
TAKARA BIO INC. 0.97% 2809 End-of-day quote.1.48%
TAKEDA PHARMACEUTICAL COMPANY LIMITED -0.25% 3600 End-of-day quote.-4.13%
All news about DAICEL CORPORATION
2020DAICEL CORPORATION : Ex-dividend day for interim dividend
FA
2020DAICEL CORPORATION : Ex-dividend day for final dividend
FA
2020DAICEL CORPORATION : Anniversary bonus dividend
FA
2020Pharma firm Anges and Osaka University to begin testing coronavirus vaccine o..
RE
2019DAICEL CORP : Ex-dividend day for interim dividend
FA
2019DAICEL CORP : Ex-dividend day for final dividend
FA
2019DAICEL CORP : quaterly earnings release
2018DAICEL CORP : Ex-dividend day for interim dividend
FA
2018DAICEL CORP : Ex-dividend day for final dividend
FA
2017DAICEL CORP : Ex-dividend day for interim dividend
FA
More news
Financials
Sales 2021 374 B 3 598 M 3 598 M
Net income 2021 14 358 M 138 M 138 M
Net Debt 2021 176 B 1 693 M 1 693 M
P/E ratio 2021 16,2x
Yield 2021 4,20%
Capitalization 235 B 2 262 M 2 264 M
EV / Sales 2021 1,10x
EV / Sales 2022 1,04x
Nbr of Employees 11 606
Free-Float 93,1%
Chart DAICEL CORPORATION
Duration : Period :
Daicel Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DAICEL CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 831,88 JPY
Last Close Price 762,00 JPY
Spread / Highest target 50,9%
Spread / Average Target 9,17%
Spread / Lowest Target -8,79%
EPS Revisions
Managers and Directors
NameTitle
Yoshimi Ogawa President & Representative Director
Misao Fudaba Chairman
Masafumi Nogimori Independent Outside Director
Kunie Okamoto Independent Outside Director
Teisuke Kitayama Independent Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
DAICEL CORPORATION1.20%2 210
LG CHEM, LTD.21.00%66 202
DOW INC.3.69%42 688
FORMOSA PLASTICS CORPORATION-3.32%21 179
FORMOSA CHEMICALS & FIBRE CORPORATION-1.89%17 351
COVESTRO AG8.76%12 848